Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis.
Shozu M, Fukami M, Ogata T.
Expert Rev Endocrinol Metab. 2014 Jul;9(4):397-409. doi: 10.1586/17446651.2014.926810.
Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
Fukami M, Miyado M, Nagasaki K, Shozu M, Ogata T.
Pediatr Endocrinol Rev. 2014 Mar;11(3):298-305.
Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
Binder G, Nakamura A, Schweizer R, Ogata T, Fukami M, Nagasaki K.
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1491-1500. doi: 10.1210/clinem/dgab054.
Long term effects of aromatase inhibitor treatment in patients with aromatase excess syndrome.
Giannopoulou EZ, Brandt S, Zorn S, Denzer C, von Schnurbein J, Fukami M, Kaiser A, Schmidt M, Wabitsch M.
Front Endocrinol (Lausanne). 2024 Nov 20;15:1487884. doi: 10.3389/fendo.2024.1487884. eCollection 2024.
Aromatase excess syndrome in a family with upstream deletion of CYP19A1.
Shihara D, Miyado M, Nakabayashi K, Shozu M, Ogata T, Nagasaki K, Fukami M.
Clin Endocrinol (Oxf). 2014 Aug;81(2):314-6. doi: 10.1111/cen.12329. Epub 2013 Oct 18.
Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2.
Tan X, Wu X, Chen J, Wu Y, Li S, Chen X, Zhang X.
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):85-88. doi: 10.1515/jpem-2018-0266.
Aromatase and gynecomastia.
Braunstein GD.
Endocr Relat Cancer. 1999 Jun;6(2):315-24. doi: 10.1677/erc.0.0060315.
Aromatase excess syndrome presenting with prepubertal gynecomastia in an Egyptian child with type 1 neurofibromatosis.
Metwalley KA, Farghaly HS.
Indian J Hum Genet. 2013 Oct;19(4):472-4. doi: 10.4103/0971-6866.124379.
Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
Fukami M, Shozu M, Soneda S, Kato F, Inagaki A, Takagi H, Hanaki K, Kanzaki S, Ohyama K, Sano T, Nishigaki T, Yokoya S, Binder G, Horikawa R, Ogata T.
J Clin Endocrinol Metab. 2011 Jun;96(6):E1035-43. doi: 10.1210/jc.2011-0145. Epub 2011 Apr 6.
[A clinical case of aromatase excess syndrome associated with 15Q21.2 duplication].
Kasyanova YV, Chernyak IY, Voronina IK, Kalinchenko NY.
Probl Endokrinol (Mosk). 2020 Aug 30;66(2):79-84. doi: 10.14341/probl12446.
